The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients

BACKGROUND & AIMS: Hyperbaric oxygen therapy (HBOT) is a promising treatment for moderate-to-severe ulcerative colitis. However, our current understanding of the host and microbial response to HBOT remains unclear. This study examined the molecular mechanisms underpinning HBOT using a multi-omic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Carlos G., Mills, Robert H., Kordahi, Melissa C., Carrillo-Terrazas, Marvic, Secaira-Morocho, Henry, Widjaja, Christella E., Tsai, Matthew S., Mittal, Yash, Yee, Brian A., Vargas, Fernando, Weldon, Kelly, Gauglitz, Julia M., Delaroque, Clara, Sauceda, Consuelo, Rossitto, Leigh-Ana, Ackermann, Gail, Humphrey, Gregory, Swafford, Austin D., Siegel, Corey A., Buckey, Jay C., Raffals, Laura E., Sadler, Charlotte, Lindholm, Peter, Fisch, Kathleen M., Valaseck, Mark, Suriawinata, Arief, Yeo, Gene W., Ghosh, Pradipta, Chang, John T., Chu, Hiutung, Dorrestein, Pieter, Zhu, Qiyun, Chassaing, Benoit, Knight, Rob, Gonzalez, David J., Dulai, Parambir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117812/
https://www.ncbi.nlm.nih.gov/pubmed/35378331
http://dx.doi.org/10.1016/j.jcmgh.2022.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117812/
https://www.ncbi.nlm.nih.gov/pubmed/35378331
http://dx.doi.org/10.1016/j.jcmgh.2022.03.008

Ejemplares similares